Lifileucel (Amtagvi) is an approved tumor-infiltrating lymphocyte (TIL) therapy for patients with advanced melanoma, but there are limited data on treatment of patients with brain ...
Oncopatch represents a meaningful addition to the treatment landscape for skin cancer…particularly in situations where ...
Metropolitan Dermatology is proud to announce the opening of its newest office in Williamstown, New Jersey, marking the practice's 23rd location and expanding access to high-quality dermatologic care ...
Meet 5 hot biotechs in Arizona, from Phoenix to Tucson, that have raised significant funding over the past decade.
Biomedical scientist Dr Judey Pretorius argues that your skin shouldn’t reveal your struggle, but for millions in South ...
After a Stage 1B melanoma diagnosis, Troy Regional education coordinator Whitney Barron traveled to Washington, D.C., to ...
OncoPatch announced today that it received FDA 510(k) for its Oncopatch Surface brachytherapy system for treating localized tumors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results